YOU Liangshun, Hematology

Program Overview

This program is designed to provide advanced training for researchers and students in the fields of hematology and molecular biology, with a specific focus on rare diseases such as Castleman disease. The program aims to enhance graduate students' awareness of rare diseases, deepen their theoretical knowledge, and develop their practical skills, preparing them for distinguished careers in academia or the biomedical industry. Target participants include graduate students.


Program Highlights

· Access to cutting-edge research platforms, fostering rigorous scientific thinking and promoting precision in scientific methodologies.

· Offering clinical and experimental researches in hematological rare diseases.

· Hands-on training in advanced experimental techniques and access to world-class facilities.

· Research funding support for studies in cell and molecular biology.

· Assistance with experimental data analysis, statistical interpretation, scientific writing, publishing research articles, and preparing for conference presentations. 

Training Objectives

· Develop an in-depth understanding of the clinical diagnosis and treatment of Castleman disease

· Investigate the immune-regulatory mechanism of Castleman disease

· Acquire expertise in disease-related multi-omics analysis

· Cultivate skills in scientific writing

Program Duration

52 weeks

Research Overview

Research fields:

Castleman Disease, iMCD, Hematological Malignances, Immunotherapy, Inflammation


Research Focus:

· Clinical diagnosis and treatment strategies for Castleman disease

· Multi-omics analysis of the immune landscape and immune-regulatory mechanisms in Castleman disease

· Exploring novel therapeutic strategies for iMCD


Projects:

· Multi-omics immune landscape of Castleman disease

· Development of a humanized IL-6-restricted iMCD mouse model for mechanism verification 

· Identification of cytokine origins and inflammatory storms in Castleman disease

· Investigation of metabolic changes and their molecular mechanisms in the progression of iMCD 

Target Audience & Qualifications

Graduate students:

Candidates must be enrolled in a Master's, M.D. or Ph.D. program in clinical medicine, biomedicine, immunology, or a related field. Familiarity with research methodologies and laboratory techniques is required. Fluency in English is mandatory.


Program Agenda

Engaged in full-time research activities

Evaluation and Feedback

Assessment Methods:

· Written progress reports at 6-months of program and upon completion of the program

· Presentation at lab meetings


Feedback for Participants:

Participants can submit anonymous feedback via an online form at the end of the program. One-on-one feedback sessions will also be scheduled midway through the program.


Fees

The program is free of charge.